Structured education programme for women with polycystic ovary syndrome: a randomised controlled trial

被引:11
|
作者
Mani, Hamidreza [1 ,2 ]
Chudasama, Yogini [1 ]
Hadjiconstantinou, Michelle [1 ]
Bodicoat, Danielle H. [1 ]
Edwardson, Charlotte [1 ,3 ,4 ]
Levy, Miles J. [2 ]
Gray, Laura J. [5 ]
Barnett, Janette [2 ]
Daly, Heather [6 ]
Howlett, Trevor A. [2 ]
Khunti, Kamlesh [1 ]
Davies, Melanie J. [1 ]
机构
[1] Univ Leicester, Leicester Gen Hosp, Leicester Diabet Ctr, Diabet Res Ctr, Leicester, Leics, England
[2] Univ Hosp Leicester NHS Trust, Leicester Royal Infirm, Dept Diabet & Endocrinol, Leicester, Leics, England
[3] Leicester Biomed Res Ctr, Leicester, Leics, England
[4] Leicester Biomed Res Ctr, Loughborough, Leics, England
[5] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England
[6] Thurmaston Hlth Ctr, Leicester Med Grp, Leicester, Leics, England
来源
ENDOCRINE CONNECTIONS | 2018年 / 7卷 / 01期
关键词
polycystic ovary syndrome; structured education; physical activity; attrition rate; quality of life; illness perception; SELF-MANAGEMENT;
D O I
10.1530/EC-17-0274
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To evaluate the effectiveness of a structured education programmes in women with polycystic ovary syndrome (PCOS). Methods: Single-centre, randomised controlled trial, testing a single exposure to a group-based, face-to-face, structured education programme. Inclusion criteria were women with PCOS, aged 18-49 years inclusive and body mass index >= 23 kg/m(2) for black and minority ethnicities or >= 25 kg/m(2) for white Europeans. Primary outcome was step-count/day at 12 months. Secondary outcomes included indices of physical activity, cardiovascular risk factors, quality of life (QoL) and illness perception (IP). Results: 161 women were included (78 control, 83 intervention); 69% white; mean age 33.4 (S.D. 7.6) years, of whom 100 (48 intervention; 52 control) attended their 12-month visit (38% attrition). 77% of the intervention arm attended the education programme. No significant change in step-count was observed at 12 months (mean difference: + 351 steps/day (95% confidence interval -481, + 1183); P = 0.40). No differences were found in biochemical or anthropometric outcomes. The education programme improved participants' IP in 2 dimensions: understanding their PCOS (P < 0.001) and sense of control (P < 0.01) and improved QoL in 3 dimensions: emotions (P < 0.05), fertility (P < 0.05), weight (P < 0.01) and general mental well-being (P < 0.01). Discussion: A single exposure to structured education programme did not increase physical activity or improve biochemical markers in overweight and obese women with PCOS. However, providing a structured education in parallel to routine medical treatment can be beneficial for participants' understanding of their condition, reducing their anxiety and improving their QoL.
引用
收藏
页码:26 / 35
页数:10
相关论文
共 50 条
  • [21] A randomized sham-controlled trial of manual acupuncture for infertile women with polycystic ovary syndrome
    Pan, Wen
    Li, Feng-xing
    Wang, Qiao
    Huang, Zou-qin
    Yan, Yu-ming
    Zhao, Ling
    Shen, Xue-yong
    [J]. INTEGRATIVE MEDICINE RESEARCH, 2022, 11 (02)
  • [22] Efficacy of acupuncture on menstrual frequency in women with polycystic ovary syndrome Protocol for a randomized, controlled trial
    Zhou, Jing
    Yang, Likun
    Yu, Jinna
    Wang, Yang
    Liu, Zhishun
    [J]. MEDICINE, 2017, 96 (47)
  • [23] Myoinositol vs. Metformin in Women with Polycystic Ovary Syndrome: A Randomized Controlled Clinical Trial
    Ravn, Pernille
    Gram, Freja
    Andersen, Marianne S. S.
    Glintborg, Dorte
    [J]. METABOLITES, 2022, 12 (12)
  • [24] Exercise training and reproductive outcomes in women with polycystic ovary syndrome: A pilot randomized controlled trial
    Benham, Jamie L.
    Booth, Jane E.
    Corenblum, Bernard
    Doucette, Steve
    Friedenreich, Christine M.
    Rabi, Doreen M.
    Sigal, Ronald J.
    [J]. CLINICAL ENDOCRINOLOGY, 2021, 95 (02) : 332 - 343
  • [25] Effects of Diane-35 and Marvelon in women with polycystic ovary syndrome: a randomized, controlled trial
    Cheng, Ran
    Ma, Yaxian
    Su, Mi
    Xu, Liangzhi
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2016, 32 : 124 - 125
  • [26] The feasibility of progressive resistance training in women with polycystic ovary syndrome: A pilot randomized controlled trial
    Vizza L.
    Smith C.A.
    Swaraj S.
    Agho K.
    Cheema B.S.
    [J]. BMC Sports Science, Medicine and Rehabilitation, 8 (1)
  • [27] The Pharmacogenetics of Metformin in Women with Polycystic Ovary Syndrome: A Randomized Trial
    Pedersen, Andreas J. T.
    Stage, Tore Bjerregaard
    Glintborg, Dorte
    Andersen, Marianne
    Christensen, Mette Marie Hougaard
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 122 (02) : 239 - 244
  • [28] Structured group education programme and accompanying mHealth intervention to promote physical activity in women with a history of gestational diabetes: A randomised controlled trial
    Khunti, Kamlesh
    Sukumar, Nithya
    Waheed, Ghazala
    Gillies, Clare
    Dallosso, Helen
    Brough, Chris
    Davies, Melanie J.
    Fitzpatrick, Claire
    Gray, Laura J.
    Highton, Patrick
    Rowlands, Alex
    Schreder, Sally
    Yates, Tom
    Saravanan, Ponnusamy
    [J]. DIABETIC MEDICINE, 2023, 40 (07)
  • [29] A randomised controlled trial on the effects of a structural education module among women with polycystic ovarian syndrome on nutrition and physical activity changes
    Sareh Dashti
    Habibah Abdul Hamid
    Suriani Mohamad Saini
    Maiza Tusimin
    Maimunah Ismail
    Ali Jafarzadeh Esfehani
    Siew Mooi Ching
    Kai Wei Lee
    Norzian Ismail
    Jie Lin Wong
    Latiffah Abdul Latiff
    [J]. BMC Women's Health, 22
  • [30] A randomised controlled trial on the effects of a structural education module among women with polycystic ovarian syndrome on nutrition and physical activity changes
    Dashti, Sareh
    Abdul Hamid, Habibah
    Mohamad Saini, Suriani
    Tusimin, Maiza
    Ismail, Maimunah
    Jafarzadeh Esfehani, Ali
    Ching, Siew Mooi
    Lee, Kai Wei
    Ismail, Norzian
    Wong, Jie Lin
    Abdul Latiff, Latiffah
    [J]. BMC WOMENS HEALTH, 2022, 22 (01)